The promise and paradox of HIV self-testing in the era of twice-yearly PrEP

On July 12, WHO issued new guidelines recommending twice-yearly injectable lenacapavir as an additional option within combination HIV prevention—a pivotal moment in global prevention efforts. Relative to daily oral tenofovir disoproxil…